Seegene Inc

Select Menu

Press Release You can check out news about Seegene from various media

Jan. 17
2022

Seegene’s Allplex™ SARS CoV-2 FluA/FluB/RSV Assay approved under Health Canada’s Interim Order

- Seegene’s syndromic assay detects COVID-19 and Influenza A/B/RSV infections in a single test.Seegene Inc. (KQ 096530), South Korea's leading molecular diagnostic company, announced it has received...

PR Newswire
Jan. 17
2022

Seegene Continues to Support Israel’s Effort to Manage the Omicron Variant With Timely Delivery of Five Million Tests

- Seegene to export COVID-19 test that detects COVID-19 and Omicron along with its Master Assay that distinguishes between COVID-19 and other respiratory viruses Seegene Inc. (KQ 096530), South...

PR Newswire
Jan. 13
2022

Seegene Unveils Blueprint for the Future of Molecular Diagnostics, Including Open Development Platform at the 40th Annual J.P. Morgan Healthcare Conference

Seegene Inc. (KQ 096530), South Korea’s leading molecular diagnostics (MDx) company, today, unveiled its blueprint for the future during a presentation at the 40th annual J.P. Morgan Healthcare vir...

PR Newswire
Dec. 29
2021

Seegene Airlifts 1.7 million COVID-19 Tests to Israel Battling the Omicron Variant by a charter plane

- On December 29, Seegene to deliver Allplex™ SARS-CoV-2 Master Assay that can preemptively detect the Omicron variant at the primary screening stage- Earlier this month, the company has hired a pr...

PR Newswire
Dec. 09
2021

Seegene Rapidly Introduces New PCR Test that Identifies the Omicron Variant, its Stealth Version, and all VOCs in a single tube

- The new assay identifies positive COVID-19 cases and distinguishes between Alpha, Beta, Gamma, Delta, Omicron and its Stealth version. South Korea’s leading molecular diagnostics company, today un...

PR Newswire
Nov. 30
2021

Seegene’s High Multiplex PCR Assay Capable of Detecting New Omicron Variant

- The Allplex™ SARS-CoV-2 Master Assay can simultaneously detect the wild-type coronavirus and the Omicron variant in a single test tube. - Seegene will support countries in need of diagnostics to hel...

PR Newswire
Nov. 23
2021

Seegene Announces Q3 2021 Earnings, Continuing COVID-Era Momentum

- Q3 Revenue held steady at KRW 305.3 billion- Operating profit dipped slight due to powerful investment in R&D- Scheduled to introduce new diagnostic tests capable of screening 22 targets, i...

PR Newswire
Nov. 15
2021

Seegene Opens New Subsidiary in Bogotá, Colombia, to Advance Regional COVID-19 Testing

Seegene Inc. (KQ 096530), a leading biotechnology firm specializing in molecular diagnostics (MDx), has announced the opening of an eighth global subsidiary, strategically located in Bogotá, Colombi...

PR Newswire
Oct. 27
2021

Launch of Seegene’s STARlet-AIOS: All-in-One System Fulfills Critical Need for Fully Automated, High-Throughput Real-Time PCR Testing

- A true walk away ‘sample to answer’ molecular diagnostic system designed for high throughput testing, offering a time-efficient and seamless workflow for clinical laboratories- Utilizes Seegene’s ...

PR Newswire
Sep. 27
2021

Seegene Unveils Fully Automated Molecular Testing System at the 2021 AACC

- Seegene unveils its first fully automated MDx system, STARlet-AIOS: All-in-One System at the 2021 AACC held in the Atlanta, GA, United States- AIOS is the MDx system that integrates Seegene’s ...

PR Newswire
Sep. 01
2021

Seegene Receives CE-IVD Mark for Use of Combo Swab, a Self-Collection Device with Four COVID-19 Diagnostic Tests

Seegene Inc. (KQ 096530), South Korea’s leading molecular diagnostics company announced on August 20, that it has obtained CE marking for the use of Combo Swab, a self-collection device with four d...

PR Newswire
Aug. 16
2021

Seegene Q2 2021 Earnings Show 11 Percent Revenue Growth, YoY

- Revenue of KRW 303.7 billion ($269.1 million) is record for second quarter, up 11 percent year-over-year - 1H’21 Revenue at KRW 655.5 billion ($580.8 million), 58 percent achievement based on t...

PR Newswire
Jul. 13
2021

Seegene Introduces New SARS-CoV-2 Variants Detection Test That Can Screen Six Virus Variants Including the Delta and Delta Plus

- Seegene launches new multiplex PCR test capable of screening six SARS-CoV-2 variants including the Delta and Delta Plus variants attributable for a recent surge in global COVID-19 cases. - The ...

PR Newswire
Jun. 30
2021

Seegene announces partnership with Bio-Rad to develop diagnostic testing products for the U.S. Market

- Seegene announces partnership with Bio-Rad for the development and commercialization of infectious disease molecular diagnostic products - Diagnostic tests designed for the pandemic and the po...

PR Newswire

1 2 3 4 5

Choose your location

Choose your country

Press Release You can check out news about Seegene from various media

Seegene’s Allplex™ SARS CoV-2 FluA/FluB/RSV Assay approved under Health Canada’s Interim Order

Seegene Continues to Support Israel’s Effort to Manage the Omicron Variant With Timely Delivery of Five Million Tests

Seegene Unveils Blueprint for the Future of Molecular Diagnostics, Including Open Development Platform at the 40th Annual J.P. Morgan Healthcare Conference

Seegene Airlifts 1.7 million COVID-19 Tests to Israel Battling the Omicron Variant by a charter plane

Seegene Rapidly Introduces New PCR Test that Identifies the Omicron Variant, its Stealth Version, and all VOCs in a single tube

Seegene’s High Multiplex PCR Assay Capable of Detecting New Omicron Variant

Seegene Announces Q3 2021 Earnings, Continuing COVID-Era Momentum

Seegene Opens New Subsidiary in Bogotá, Colombia, to Advance Regional COVID-19 Testing

Launch of Seegene’s STARlet-AIOS: All-in-One System Fulfills Critical Need for Fully Automated, High-Throughput Real-Time PCR Testing

Seegene Unveils Fully Automated Molecular Testing System at the 2021 AACC

Seegene Receives CE-IVD Mark for Use of Combo Swab, a Self-Collection Device with Four COVID-19 Diagnostic Tests

Seegene Q2 2021 Earnings Show 11 Percent Revenue Growth, YoY

Seegene Introduces New SARS-CoV-2 Variants Detection Test That Can Screen Six Virus Variants Including the Delta and Delta Plus

Seegene announces partnership with Bio-Rad to develop diagnostic testing products for the U.S. Market